A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis

OBJECTIVE: To determine the steroid-sparing effect of methotrexate (MTX) in patients with symptomatic generalized myasthenia gravis (MG). METHODS: We performed a 12-month multicenter, randomized, double-blind, placebo-controlled trial of MTX 20 mg orally every week vs placebo in 50 acetylcholine rec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurology
Autors principals: Pasnoor, Mamatha, He, Jianghua, Herbelin, Laura, Burns, Ted M., Nations, Sharon, Bril, Vera, Wang, Annabel K., Elsheikh, Bakri H., Kissel, John T., Saperstein, David, Shaibani, J. Aziz, Jackson, Carlayne, Swenson, Andrea, Howard, James F., Goyal, Namita, David, William, Wicklund, Matthew, Pulley, Michael, Becker, Mara, Mozaffar, Tahseen, Benatar, Michael, Pazcuzzi, Robert, Simpson, Ericka, Rosenfeld, Jeffrey, Dimachkie, Mazen M., Statland, Jeffrey M., Barohn, Richard J.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4932232/
https://ncbi.nlm.nih.gov/pubmed/27306628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000002795
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars